| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | K3D9A0ICQ3 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tumor necrosis factor ligand superfamily member 13B inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Optic Neuritis | 2 | D009902 | ClinicalTrials |
| Glomerulonephritis, IGA | 2 | D005922 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 845264-92-8 |
| ChEMBL | CHEMBL1742986 |
| FDA SRS | K3D9A0ICQ3 |
| Guide to Pharmacology | 9517 |
CONTENTS